ACM
BIOA

AH Capital Management’s BioAge Labs BIOA Stock Holding History

AH Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.5M Hold
3,233,170
– – 4.38% 7
2025
Q4 		$44.1M Hold
3,233,170
– – 2.79% 8
2025
Q3 		$19M Hold
3,233,170
– – 1.36% 7
2025
Q2 		$13.4M Hold
3,233,170
– – 4.27% 5
2025
Q1 		$12.2M Hold
3,233,170
– – 1.73% 8
2024
Q4 		$18.7M Buy
3,233,170
+219,195
+7% +$3.78M 2.51% 6
2024
Q3 		$62.7M Buy
+3,013,975
New +$60.4M 5.51% 6

Other funds holding BIOA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

AH Capital Management's BIOA Position: Q1 2026 in Review

AH Capital Management held its BioAge Labs (BIOA) position steady in Q1 2026 at 3,233,170 shares worth $56.5M. The position accounts for 4.38% of the portfolio, ranked #7.

AH Capital Management first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. The position peaked at $62.7M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • AH Capital Management held 3,233,170 shares of BioAge Labs worth $56.5M as of Q1 2026.
  • AH Capital Management left its BioAge Labs share count unchanged in Q1 2026.
  • BioAge Labs made up 4.38% of AH Capital Management's portfolio in Q1 2026, its #7 holding.
  • AH Capital Management first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • AH Capital Management's BioAge Labs position peaked at $62.7M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on AH Capital Management's 13F filing for Q1 2026, filed 15 May 2026.